234 related articles for article (PubMed ID: 19917783)
1. Development of focal segmental glomerulosclerosis after anabolic steroid abuse.
Herlitz LC; Markowitz GS; Farris AB; Schwimmer JA; Stokes MB; Kunis C; Colvin RB; D'Agati VD
J Am Soc Nephrol; 2010 Jan; 21(1):163-72. PubMed ID: 19917783
[TBL] [Abstract][Full Text] [Related]
2. The development of focal segmental glomerulosclerosis secondary to anabolic steroid abuse.
Harrington P; Ali G; Chan A
BMJ Case Rep; 2011 Dec; 2011():. PubMed ID: 22669525
[TBL] [Abstract][Full Text] [Related]
3. Tip lesion variant of primary focal and segmental glomerulosclerosis: clinicopathological analysis of 20 cases.
Mungan S; Turkmen E; Aydin MC; Saglam AE; Baydar DE
Ren Fail; 2015 Jun; 37(5):858-65. PubMed ID: 25857429
[TBL] [Abstract][Full Text] [Related]
4. Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis.
Hodgin JB; Rasoulpour M; Markowitz GS; D'Agati VD
Clin J Am Soc Nephrol; 2009 Jan; 4(1):71-6. PubMed ID: 19019999
[TBL] [Abstract][Full Text] [Related]
5. Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.
Markowitz GS; Nasr SH; Stokes MB; D'Agati VD
Clin J Am Soc Nephrol; 2010 Apr; 5(4):607-15. PubMed ID: 20203164
[TBL] [Abstract][Full Text] [Related]
6. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
7. Obesity-related glomerulopathy: an emerging epidemic.
Kambham N; Markowitz GS; Valeri AM; Lin J; D'Agati VD
Kidney Int; 2001 Apr; 59(4):1498-509. PubMed ID: 11260414
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study.
Valeri A; Barisoni L; Appel GB; Seigle R; D'Agati V
Kidney Int; 1996 Nov; 50(5):1734-46. PubMed ID: 8914044
[TBL] [Abstract][Full Text] [Related]
9. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
[TBL] [Abstract][Full Text] [Related]
10. Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy.
Markowitz GS; Radhakrishnan J; Kambham N; Valeri AM; Hines WH; D'Agati VD
J Am Soc Nephrol; 2000 Aug; 11(8):1439-1448. PubMed ID: 10906157
[TBL] [Abstract][Full Text] [Related]
11. Focal and segmental glomerulosclerosis: does prognosis vary with the variants?
Swarnalatha G; Ram R; Ismal KM; Vali S; Sahay M; Dakshinamurty KV
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):173-81. PubMed ID: 25579744
[TBL] [Abstract][Full Text] [Related]
12. Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations.
Greenberg A; Bastacky SI; Iqbal A; Borochovitz D; Johnson JP
Am J Kidney Dis; 1997 Mar; 29(3):334-44. PubMed ID: 9041208
[TBL] [Abstract][Full Text] [Related]
13. Focal Segmental Glomerulosclerosis (FSGS) Progressing to Collapsing Glomerulopathy in Renal Transplant Recipients With and Without COVID-19 Infection.
Thorburn CA; Samarapungavan D; Kanaan HD; Cohn S; Jabbar KJ; Li W; Bedi D; Suliman ST; Patel PJ; Putchakayala K; Singh A; Zhang PL
Transplant Proc; 2022; 54(6):1465-1470. PubMed ID: 35341587
[TBL] [Abstract][Full Text] [Related]
14. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
[TBL] [Abstract][Full Text] [Related]
15. [Collapsing Glomerulopathy Secondary to Anabolic Steroids for Bodybuilding: A Case Series].
Passaro R; D'Angiò P; Laurino S; Gigliotti G; Massa A; Mancini A; Gonnella A; Giammarino A; Borriello G
G Ital Nefrol; 2023 Oct; 40(5):. PubMed ID: 38010246
[TBL] [Abstract][Full Text] [Related]
16. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of Interstitial Nephritis and the Cellular Variant of Focal Segmental Glomerulosclerosis Secondary to Anabolic Steroid Abuse.
Al-Hwiesh A; Al-Amoudi K; Alshehabi K; Abdelgalil M; Al-Hwiesh B; Alhwiesh A; Al-Audah N; Al Solami SM; Hamza WM; Abdul-Rahman IS
Saudi J Kidney Dis Transpl; 2022 Nov; 33(6):839-843. PubMed ID: 38018725
[TBL] [Abstract][Full Text] [Related]
18. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis.
Pokhariyal S; Gulati S; Prasad N; Sharma RK; Singh U; Gupta RK; Mittal S; Mehta B
J Nephrol; 2003; 16(5):691-6. PubMed ID: 14733415
[TBL] [Abstract][Full Text] [Related]
19. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.
Laurin LP; Gasim AM; Derebail VK; McGregor JG; Kidd JM; Hogan SL; Poulton CJ; Detwiler RK; Jennette JC; Falk RJ; Nachman PH
Clin J Am Soc Nephrol; 2016 Oct; 11(10):1752-1759. PubMed ID: 27445167
[TBL] [Abstract][Full Text] [Related]
20. A case of recurrent focal segmental glomerulosclerosis after kidney transplantation associated with variant conversion in the Columbia classification.
Unagami K; Kawanishi K; Shimizu T; Kanzawa T; Toki D; Okumi M; Omoto K; Horita S; Koike J; Honda K; Nagashima Y; Ishida H; Tanabe K; Nitta K
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():96-100. PubMed ID: 26031598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
